Carlo Farina
Novartis (Switzerland)(CH)
Publications by Year
Research Areas
ATP Synthase and ATPases Research, Pain Mechanisms and Treatments, Neuropeptides and Animal Physiology, Mitochondrial Function and Pathology, Receptor Mechanisms and Signaling
Most-Cited Works
- → Discovery of a Novel Antitumor Benzolactone Enamide Class That Selectively Inhibits Mammalian Vacuolar-Type (H+)-ATPases(2001)142 cited
- → A selective inhibitor of the osteoclastic V-H+-ATPase prevents bone loss in both thyroparathyroidectomized and ovariectomized rats(2000)129 cited
- → Synthesis and anti-ulcer activity of new derivatives of glycyrrhetic, oleanolic and ursolic acids(1998)110 cited
- → Percutaneous transluminal angioplasty versus surgery for subclavian artery occlusive disease(1989)109 cited
- → Elevated levels of a C-terminal agrin fragment identifies a new subset of sarcopenia patients(2012)104 cited
- → Discovery of a Novel Class of Selective Non-Peptide Antagonists for the Human Neurokinin-3 Receptor. 1. Identification of the 4-Quinolinecarboxamide Framework(1997)79 cited
- → Long-term outcome after transaxillary approach for thoracic outlet syndrome(1995)78 cited
- → 5-(5,6-Dichloro-2-indolyl)-2-methoxy-2,4-pentadienamides: Novel and Selective Inhibitors of the Vacuolar H+-ATPase of Osteoclasts with Bone Antiresorptive Activity(1998)68 cited
- → Discovery of a Novel Class of Selective Non-Peptide Antagonists for the Human Neurokinin-3 Receptor. 2. Identification of (S)-N-(1-Phenylpropyl)-3-hydroxy-2- phenylquinoline-4-carboxamide (SB 223412)(1999)63 cited
- → Synthesis and Structure−Activity Relationships of Bafilomycin A1 Derivatives as Inhibitors of Vacuolar H+-ATPase(1998)61 cited